Undervalued Small-Cap Stocks on NAS January 2026

January 01, 2026

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the NAS

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
NMRA Neumora Therapeutics, Inc 2.16 11.45 9.29 (430.1%) 2366480 348.7 0.0 0.0
BCYC Bicycle Therapeutics Ltd 6.74 23.45 16.70 (247.8%) 375995 466.4 0.0 0.0
RCKT Rocket Pharmaceuticals In 3.03 10.45 7.42 (244.9%) 2075845 333.6 0.0 0.0
CCOI Cogent Communications Gro 17.89 60.60 42.71 (238.7%) 2086803 852.9 0.0 0.0
KROS Keros Therapeutics Inc 17.32 58.04 40.72 (235.1%) 1270029 710.5 0.0 0.0
GERN Geron Corporation 1.16 3.87 2.71 (233.8%) 8711590 772.5 0.0 0.0
HELE Helen of Troy Ltd 18.37 55.53 37.16 (202.3%) 792164 423.7 0.0 0.0
XRX Xerox Corp 2.73 8.17 5.44 (199.3%) 4686833 341.8 0.0 0.0
DNUT Krispy Kreme Inc 3.98 11.37 7.39 (185.7%) 5521814 677.8 0.0 0.0
MYGN Myriad Genetics Inc 7.91 21.96 14.05 (177.6%) 1258857 723.0 0.0 0.0
All data provided as at market close November 24, 2025.

Company Details

Neumora Therapeutics, Inc

NMRA:NAS

Close Price

2.16

Our Valuation

11.45

% Difference

430.09

Market Cap ($M)

349

P/E Ratio

0.0

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder.

Access the stockcalc valuation


Bicycle Therapeutics Ltd

BCYC:NAS

Close Price

6.74

Our Valuation

23.45

% Difference

247.85

Market Cap ($M)

466

P/E Ratio

0.0

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

Access the stockcalc valuation


Rocket Pharmaceuticals In

RCKT:NAS

Close Price

3.03

Our Valuation

10.45

% Difference

244.95

Market Cap ($M)

334

P/E Ratio

0.0

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Access the stockcalc valuation


Cogent Communications Gro

CCOI:NAS

Close Price

17.89

Our Valuation

60.60

% Difference

238.74

Market Cap ($M)

853

P/E Ratio

0.0

Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, South America, Europe, Oceania, and Africa.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Keros Therapeutics Inc

KROS:NAS

Close Price

17.32

Our Valuation

58.04

% Difference

235.10

Market Cap ($M)

710

P/E Ratio

0.0

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Access the stockcalc valuation


Geron Corporation

GERN:NAS

Close Price

1.16

Our Valuation

3.87

% Difference

233.83

Market Cap ($M)

772

P/E Ratio

0.0

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Access the stockcalc valuation


Helen of Troy Ltd

HELE:NAS

Close Price

18.37

Our Valuation

55.53

% Difference

202.27

Market Cap ($M)

424

P/E Ratio

0.0

Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates in two segments: Home & Outdoor and Beauty & Wellness.

Access the stockcalc valuation


Xerox Corp

XRX:NAS

Close Price

2.73

Our Valuation

8.17

% Difference

199.27

Market Cap ($M)

342

P/E Ratio

0.0

Xerox Holdings Corporation, together with its subsidiaries, operates as a workplace technology company that integrates hardware, services, and software for enterprises in North America, Latin America, Europe, the Middle East, Africa, India, and internationally. It operates in two segments: Print and Other, and Xerox Financial Services (XFS).

Access the stockcalc valuation


Krispy Kreme Inc

DNUT:NAS

Close Price

3.98

Our Valuation

11.37

% Difference

185.68

Market Cap ($M)

678

P/E Ratio

0.0

Krispy Kreme, Inc., together with its subsidiaries, produces doughnuts in the United States, the United Kingdom, Ireland, Australia, New Zealand, Mexico, Canada, Japan, and internationally. It operates in three segments: U.S., International, and Market Development.

Access the stockcalc valuation


Myriad Genetics Inc

MYGN:NAS

Close Price

7.91

Our Valuation

21.96

% Difference

177.62

Market Cap ($M)

723

P/E Ratio

0.0

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Neumora Therapeutics, and Bicycle Therapeutics are the most undervalued Small-Cap stocks on the NAS. See which other companies made the Small-Cap list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-january-2026
Neumora Therapeutics, $NMRA and Bicycle Therapeutics $BCYC are the most undervalued Small-Cap stocks on the #NAS. See the full list of Small-Cap stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-january-2026
Neumora Therapeutics, and Bicycle Therapeutics are the most undervalued Small-Cap stocks on the NAS. See which other companies made the Small-Cap list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-january-2026

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.